4//SEC Filing
Forster Eliot 4
Accession 0001104659-23-101237
CIK 0001006281other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:46 PM ET
Size
5.8 KB
Accession
0001104659-23-101237
Insider Transaction Report
Form 4
Forster Eliot
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-09-14+85,715→ 85,715 totalExercise: $1.75Exp: 2033-09-14→ Common Stock (85,715 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying the stock options shall vest in 12 equal quarterly installments commencing upon the date of grant. The stock options are subject to accelerated vesting upon a corporate transaction or a change in control as described in the Protalix BioTherapeutics, Inc., Amended and Restated 2006 Stock Incentive Plan, as amended.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001831558
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 4:46 PM ET
- Size
- 5.8 KB